(18)FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients

BACKGROUND: The efficacy of neoadjuvant chemotherapy regimens in advanced luminal breast cancer patients is difficult to predict. Intrinsic properties of breast tumors, including altered gene expression profile and dynamic evaluation of metabolic properties of tumor cells using positron emission tom...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: de Cremoux, Patricia, Biard, Lucie, Poirot, Brigitte, Bertheau, Philippe, Teixeira, Luis, Lehmann-Che, Jacqueline, Bouhidel, Fatiha A., Merlet, Pascal, Espié, Marc, Resche-Rigon, Matthieu, Sotiriou, Christos, Groheux, David
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2018
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5893244/
https://ncbi.nlm.nih.gov/pubmed/29662649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24674
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares